Obsidian Therapeutics, Inc. (OBX)

NASDAQ: OBX · Real-Time Price · USD

35.00

+7.50 (27.27%)

At close: Aug 10, 2026, 4:00 PM EDT

35.70

+0.70 (2.00%)

After-hours: Aug 10, 2026, 6:18 PM EDT

Obsidian Therapeutics Financials Overview

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Operating Income	-99.34	-105.67	-91.26
Net Income	-95.25	-100.61	-83.11
Earnings Per Share	-1287.13	-2056.18	-
EPS Growth	-	-	-

Fiscal Year	Current	FY 2025	FY 2024
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Cash & Investments	58.76	80.49	168.27
Total Debt	3.6	4.28	6.81
Net Cash (Debt)	55.15	76.2	161.46
Net Cash Growth	-	-52.80%	-
Net Cash Per Share	745.25	1557.42	-

Fiscal Year	TTM	FY 2025	FY 2024
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Operating Cash Flow	-88.04	-90.39	-75
Capital Expenditures	-0.02	-0.07	-0.78
Free Cash Flow	-88.06	-90.47	-75.78
Free Cash Flow Growth	-	-	-